Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Goldman

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
International Journal of Cancer|May 7, 2002
Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancerKazuo Shirakawa, Masabumi Shibuya, Yuji Heike, et al.
The Journal of Clinical Investigation|December 1, 1976
The Sézary syndrome: a malignant proliferation of helper T cellsS Broder, R L Edelson, M A Lutzner, et al.
Diabetes|March 15, 2001
Characterization of the mouse islet-specific glucose-6-phosphatase catalytic subunit-related protein gene promoter by in situ footprinting: correlation with fusion gene expression in the islet-derived betaTC-3 and hamster insulinoma tumor cell linesL J Bischof, C C Martin, C A Svitek, et al.
The Journal of Biological Chemistry|June 22, 1999
Multiple promoter elements are required for the stimulatory effect of insulin on human collagenase-1 gene transcription. Selective effects on activator protein-1 expression may explain the quantitative difference in insulin and phorbol ester actionS C Chapman, J E Ayala, R S Streeper, et al.
The Journal of Clinical Investigation|June 1, 1984
Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factorT A Waldmann, W C Greene, P S Sarin, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 1999
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trialR B Nussenblatt, E Fortin, R Schiffman, et al.
The Journal of Experimental Medicine|November 1, 1984
Expression of interleukin 2 receptors on activated human B cellsT A Waldmann, C K Goldman, R J Robb, et al.
Cancer Research|September 1, 1985
Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemiaT A Waldmann, D L Longo, W J Leonard, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survivalP S Brown, G L Parenteau, F M Dirbas, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2007
Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1Meili Zhang, Zhengsheng Yao, Hiral Patel, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
International Journal of Cancer|May 7, 2002
Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancerKazuo Shirakawa, Masabumi Shibuya, Yuji Heike, et al.
The Journal of Clinical Investigation|December 1, 1976
The Sézary syndrome: a malignant proliferation of helper T cellsS Broder, R L Edelson, M A Lutzner, et al.
Diabetes|March 15, 2001
Characterization of the mouse islet-specific glucose-6-phosphatase catalytic subunit-related protein gene promoter by in situ footprinting: correlation with fusion gene expression in the islet-derived betaTC-3 and hamster insulinoma tumor cell linesL J Bischof, C C Martin, C A Svitek, et al.
The Journal of Biological Chemistry|June 22, 1999
Multiple promoter elements are required for the stimulatory effect of insulin on human collagenase-1 gene transcription. Selective effects on activator protein-1 expression may explain the quantitative difference in insulin and phorbol ester actionS C Chapman, J E Ayala, R S Streeper, et al.
The Journal of Clinical Investigation|June 1, 1984
Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factorT A Waldmann, W C Greene, P S Sarin, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 1999
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trialR B Nussenblatt, E Fortin, R Schiffman, et al.
The Journal of Experimental Medicine|November 1, 1984
Expression of interleukin 2 receptors on activated human B cellsT A Waldmann, C K Goldman, R J Robb, et al.
Cancer Research|September 1, 1985
Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemiaT A Waldmann, D L Longo, W J Leonard, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survivalP S Brown, G L Parenteau, F M Dirbas, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2007
Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1Meili Zhang, Zhengsheng Yao, Hiral Patel, et al.
Pageof 15